{
    "2018-03-30": [
        [
            {
                "time": "2018-03-30",
                "original_text": "[强烈推荐-A评级] 华东医药(000963)年报点评：基层推广成效显著 研发投入大幅提升",
                "features": {
                    "keywords": [
                        "华东医药",
                        "年报",
                        "基层推广",
                        "研发投入",
                        "大幅提升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "[买入-A评级] 华东医药(000963)年报点评：业绩基本符合预期 工业产品梯队分明稳健增长 研发管线品种丰富价值亟待重估",
                "features": {
                    "keywords": [
                        "华东医药",
                        "年报",
                        "业绩",
                        "工业产品",
                        "研发管线",
                        "价值重估"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "申万宏源：建议“买入”华东医药",
                "features": {
                    "keywords": [
                        "申万宏源",
                        "买入",
                        "华东医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "看好医药板块 基金称将有独立行情",
                "features": {
                    "keywords": [
                        "医药板块",
                        "基金",
                        "独立行情"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "华东医药: 业绩符合预期, 布局基层+大力研发提升工业潜力, Q4调拨业务流失致商业增速下滑",
                "features": {
                    "keywords": [
                        "华东医药",
                        "业绩",
                        "布局基层",
                        "研发",
                        "工业潜力",
                        "商业增速下滑"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "华东医药: 核心品种受益医保调整增速稳健, 加大研发投入, 创新转型可期",
                "features": {
                    "keywords": [
                        "华东医药",
                        "核心品种",
                        "医保调整",
                        "研发投入",
                        "创新转型"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-30",
                "original_text": "华东医药: 两票制实施影响收入表现, 制剂品种快速增长",
                "features": {
                    "keywords": [
                        "华东医药",
                        "两票制",
                        "收入表现",
                        "制剂品种",
                        "快速增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}